Federal Register / Vol. 73, No. 32 / Friday, February 15, 2008 / Notices 8889 

amended (5 U.S.C. Appendix 2) notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate requests for 

preclinical development resources for 

potential new therapeutics for type 1 

diabetes. The outcome of the evaluation 

will be a decision whether NIDDK 

should support the request and make 

available contract resources for 

development of the potential 

therapeutic to improve the treatment or 

prevent the development of type 1 

diabetes and its complications. The 

research proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the proposed research 

projects, the disclosure of which would 

constitute a clearly unwarranted 

invitations of personal privacy. 

Name of Committee: Type 1 Diabetes—

Rapid Access to Intervention Development 

Special Emphasis Panel; National Institute of 

Diabetes and Digestive and Kidney Diseases. 

Date: February 28, 2008. 

Time: 12:30 p.m.–2 p.m. 

Agenda: To evaluate requests for 

preclinical development resources for 

potential new therapeutics for type 1 diabetes 

and its complications. 

Place: 6707 Democracy Boulevard, 

Bethesda, MD 20892, (Telephone Conference 

Call). 

Contact Person: Dr. Myrlene Staten, Senior 

Advisor, Diabetes Translation Research, 

Division of Diabetes, Endocrinology and 

Metabolic Diseases, NIDDK, NIH, 6707 

Democracy Boulevard, Bethesda, MD 20892–

5460, 301 402–7886. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Type 1 Diabetes—

Rapid Access to Intervention Development 

Special Emphasis Panel; National Institute of 

Diabetes and Digestive and Kidney Diseases. 

Date: March 13, 2008. 

Time: 10:30 a.m.–12 p.m. 

Agenda: To evaluate requests for 

preclinical development resources for 

potential new therapeutics for type 1 diabetes 

and its complications. 

Place: 6707 Democracy Boulevard, 

Bethesda, MD 20892, (Telephone Conference 

Call). 

Contact Person: Dr. Myrlene Staten, Senior 

Advisor, Diabetes Translation Research, 

Division of Diabetes, Endocrinology and 

Metabolic Diseases, NIDDK, NIH, 6707 

Democracy Boulevard, Bethesda, MD 20892–

5460, 301 407–7886. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 98.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

February 8, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–694 Filed 2–14–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended ( 5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Library of 

Medicine Special Emphasis Panel, Loan 

Repayment Program (L30–L40). 

Date: April 23, 2008. 

Time: 12:30 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Library of Medicine, 6705 

Rockledge Drive, Suite 301, Bethesda, MD 

20817 (Telephone Conference Call). 

Contact Person: Zoe E. Huang, MD, Health 

Science Administrator, Extramural Programs, 

National Library of Medicine, NIH, 6705 

Rockledge Drive, Suite 301, Bethesda, MD 

20892–7968, 301–594–4937, 

huangz@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: February 7, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–665 Filed 2–14–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Board of Scientific Counselors, Lister 

Hill National Center for Biomedical 

Communications. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Library of Medicine, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, Lister Hill National Center for 

Biomedical Communications. 

Date: April 10–11, 2008. 

Open: April 10, 2008, 9 a.m. to 11:30 a.m. 

Agenda: Review of research and 

development programs and preparation of 

reports of the Lister Hill Center for 

Biomedical Communications. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20892. 

Closed: April 10, 2008, 11:30 a.m. to 5 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20892. 

Open: April 11, 2008, 9 a.m. to 11:15 a.m. 

Agenda: Review of research and 

development programs and preparation of 

reports of the Lister Hill Center for 

Biomedical Communications. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: Karen Steely, Program 

Assistant, Lister Hill National Center for 

Biomedical Communications, National 

Library of Medicine, Building 38A, Room 

7S709, Bethesda, MD 20892, 301–435–3137, 

ksteely@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 


rwilkins on PROD1PC63 with NOTICES